Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Cancer Immunology, Immunotherapy : CII
|
June 5, 2008
MHC-dependent desensitization of intrinsic anti-self reactivity
Cristan M Jubala, Angela R Lamerato-Kozicki, Michelle Borakove, et al.
Immunological Reviews
|
February 14, 2004
Tolerance-induced receptor selection: scope, sensitivity, locus specificity, and relationship to lymphocyte-positive selection
Djemel Aït-Azzouzene, Patrick Skog, Marc Retter, et al.
Frontiers in Immunology
|
February 21, 2022
Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies
Jacob N Peterson, Susan A Boackle, Sophina H Taitano, et al.
BMC Cancer
|
November 5, 2020
RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer
John J Tentler, Julie Lang, Anna Capasso, et al.
Nature Communications
|
June 1, 2019
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
Jennifer L Caswell-Jin, Katherine McNamara, Johannes G Reiter, et al.
Nature Communications
|
February 10, 2019
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
Jennifer L Caswell-Jin, Katherine McNamara, Johannes G Reiter, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2019
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment
Julie Lang, Anna Capasso, Kimberly R Jordan, et al.
Frontiers in Oncology
|
November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models
Julie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
Cancer Research Communications
|
October 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer
Robert W Lentz, Julie Lang, Todd M Pitts, et al.
BMJ Open
|
June 6, 2022
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations
Daniel Clark Files, Michael A Matthay, Carolyn S Calfee, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Cancer Immunology, Immunotherapy : CII
|
June 5, 2008
MHC-dependent desensitization of intrinsic anti-self reactivity
Cristan M Jubala, Angela R Lamerato-Kozicki, Michelle Borakove, et al.
Immunological Reviews
|
February 14, 2004
Tolerance-induced receptor selection: scope, sensitivity, locus specificity, and relationship to lymphocyte-positive selection
Djemel Aït-Azzouzene, Patrick Skog, Marc Retter, et al.
Frontiers in Immunology
|
February 21, 2022
Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies
Jacob N Peterson, Susan A Boackle, Sophina H Taitano, et al.
BMC Cancer
|
November 5, 2020
RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer
John J Tentler, Julie Lang, Anna Capasso, et al.
Nature Communications
|
June 1, 2019
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
Jennifer L Caswell-Jin, Katherine McNamara, Johannes G Reiter, et al.
Nature Communications
|
February 10, 2019
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
Jennifer L Caswell-Jin, Katherine McNamara, Johannes G Reiter, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2019
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment
Julie Lang, Anna Capasso, Kimberly R Jordan, et al.
Frontiers in Oncology
|
November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models
Julie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
Cancer Research Communications
|
October 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer
Robert W Lentz, Julie Lang, Todd M Pitts, et al.
BMJ Open
|
June 6, 2022
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations
Daniel Clark Files, Michael A Matthay, Carolyn S Calfee, et al.
Page
of 6